PI3Kβ controls immune evasion in PTEN-deficient breast tumours-Reference-Cited by-同舟云学术

PI3Kβ controls immune evasion in PTEN-deficient breast tumours

Published:2023-04-19 Issue:7959 Volume:617 Page:139-146
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Bergholz Johann S.^ORCID,Wang Qiwei^ORCID,Wang Qi,Ramseier Michelle,Prakadan Sanjay,Wang Weihua,Fang Rong,Kabraji Sheheryar^ORCID,Zhou Qian,Gray G. Kenneth,Abell-Hart Kayley,Xie Shaozhen,Guo Xiaocan,Gu Hao,Von Thanh,Jiang Tao,Tang Shuang,Freeman Gordon J.^ORCID,Kim Hye-Jung^ORCID,Shalek Alex K.^ORCID,Roberts Thomas M.^ORCID,Zhao Jean J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-023-05940-w.pdf

Reference62 articles.

1. Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).

2. Dong, Y. et al. PTEN functions as a melanoma tumor suppressor by promoting host immune response. Oncogene 33, 4632–4642 (2014).

3. Li, S. et al. The tumor suppressor PTEN has a critical role in antiviral innate immunity. Nat. Immunol. 17, 241–249 (2016).

4. George, S. et al. Loss of PTEN is associated with resistance to anti-PD-1 checkpoint blockade therapy in metastatic uterine leiomyosarcoma. Immunity 46, 197–204 (2017).

5. Parsa, A. T. et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat. Med. 13, 84–88 (2007).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of tumor-derived exosomes mediated immune cell reprograming in cancer;Gene;2024-10

2. Tudor-SN exacerbates pathological vascular remodeling by promoting the polyubiquitination of PTEN via NEDD4-1;Journal of Biomedical Science;2024-09-05

3. Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment;Drug Discovery Today;2024-09

4. Lymphatic system regulation of anti-cancer immunity and metastasis;Frontiers in Immunology;2024-08-15

5. Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma;Frontiers in Oncology;2024-08-14